Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment
| Autor: | Jose B Cruz Rodriguez, Hernando Garcia, David Perez Ingles |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
030204 cardiovascular system & hematology 03 medical and health sciences Folic Acid 0302 clinical medicine Internal medicine medicine Humans cardiovascular diseases 030212 general & internal medicine Myocardial infarction Stroke Minerals Vitamin C business.industry food and beverages Iron deficiency medicine.disease B vitamins Folic acid Cardiovascular Diseases Dietary Supplements Vitamin B Complex Disease prevention Cardiology and Cardiovascular Medicine business Niacin |
| Zdroj: | Current Cardiology Reports. 22 |
| ISSN: | 1534-3170 1523-3782 |
| DOI: | 10.1007/s11886-020-1270-1 |
| Popis: | The objective of this study is to explore the current literature supporting the use oral multivitamins and multi/minerals (OMVMs) for cardiovascular diseases (CVD) treatment and prevention. Data on multivitamins, vitamin C and D, coenzyme Q, calcium, and selenium, has showed no consistent benefit for the prevention of CVD, myocardial infarction, or stroke, nor was there a benefit for all-cause mortality to support their routine supplementation. Folic acid alone and B vitamins with folic acid, B6 and B12, reduce stroke, whereas niacin and antioxidants are associated with an increased risk of all-cause mortality. Iron deficiency should be avoided and treated if found, but routine supplementation to those without deficiency is not evidence based. Despite the high supplement use by the general public, there is no evidence to support the routine supplementation of oral multivitamins and multi/minerals (OVMN) for CVD prevention or treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink